NexOptic Technology Corp. and IntroMedic Co., Ltd. jointly announced that they have entered a non-binding memorandum of understanding. Capsule endoscopy is a procedure that uses a tiny wireless camera to take pictures of the digestive tract.

IntroMedic's capsule endoscopy camera sits inside a vitamin-size capsule that is swallowed. As the capsule travels through the digestive tract, the camera takes thousands of pictures that are transmitted to a recorder worn on a belt around the patients' waist. Growing in popularity, capsule endoscopy is far less invasive and more comfortable to the patient than more traditional endoscopy procedures.

Specifically, IntroMedic's MiroCam® capsule endoscope offers a broader field of view of 170 degrees which enables a more thorough diagnosis of parts of the digestive system, further its 12-hour operational time mitigates many concerns common in competitive offerings. Together with IntroMedic's patented Human Body Communication technology (HBC), its Augmented Live-body Image Colour-Spectrum Enhancement (ALICE) and its Medical Image Processing technology (MIP), MiroCam® delivers many technological advantages when compared to its competitors. NexOptic and IntroMedic initiated dialogue late in 2021 and have undergone several stages of evaluation and development since.

The announcement demonstrates both companies' positive outlook on executing a potential per capsule, licence model. If successful, this would mark the second commercial deployment of ALIISTM into medical imaging devices, a field that NexOptic is well-positioned to rapidly expand into due to demanding use-cases that are frequently dependant on small lens factors.